Specific association of TBK1 with the trans-Golgi network following STING stimulation

Cell Struct Funct. 2022 Mar 8;47(1):19-30. doi: 10.1247/csf.21080. Epub 2022 Feb 5.

Abstract

Stimulator of interferon genes (STING) is essential for the type I interferon response induced by microbial DNA or self-DNA leaked from mitochondria/nuclei. In response to the emergence of such DNAs in the cytosol, STING relocates from the endoplasmic reticulum (ER) to the Golgi, and activates TANK-binding kinase 1 (TBK1), a cytosolic kinase essential for the activation of STING-dependent downstream signalling. To understand at which subcellular compartments TBK1 becomes associated with STING, we generated cells stably expressing fluorescent protein-tagged STING (mNeonGreen-STING) and TBK1 (TBK1-mScarletI). We found that after STING stimulation, TBK1 became associated with the trans-Golgi network (TGN), not the other parts of the Golgi. STING variants that constitutively induce the type I interferon response have been identified in patients with autoinflammatory diseases named "STING-associated vasculopathy with onset in infancy (SAVI)". Even in cells expressing these constitutively active STING variants, TBK1 was found to be associated with TGN, not the other parts of the Golgi. These results suggest that TGN acts as a specific platform where STING associates with and activates TBK1.Key words: the Golgi, membrane traffic, innate immunity, STING.

Keywords: STING; innate immunity; membrane traffic; the Golgi.

MeSH terms

  • Endoplasmic Reticulum
  • Golgi Apparatus
  • Humans
  • Immunity, Innate
  • Membrane Proteins* / genetics
  • Protein Serine-Threonine Kinases* / genetics
  • Signal Transduction
  • trans-Golgi Network*

Substances

  • Membrane Proteins
  • STING1 protein, human
  • Protein Serine-Threonine Kinases
  • TBK1 protein, human

Grants and funding

This work was supported by JSPS KAKENHI Grant Numbers JP19H00974 (T.T.), JP17H06164 (K.M.), JP17H06418 (K.M.), JP20H03202 (K.M.), JP20H05307 (K.M.), and JP19J21426 (Y.K.); AMED-PRIME (17939604) (T.T.); JST-CREST (JPMJCR21E4) (K.M.), JST Center of Innovation program from Japan (JPMJCE1303) (K.M.); the Subsidy for Interdisciplinary Study and Research concerning COVID-19 (Mitsubishi Foundation) (T.T.), Grant for Basic Science Research Projects from the Sumitomo Foundation (K.M.), SGH Cancer Research Grant (K.M.), and Research Grant of the Princess Takamatsu Cancer Research Fund (K.M.)